+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "V180"

Drug Overview: TetraVax-DV - Product Thumbnail Image

Drug Overview: TetraVax-DV

  • Drug Pipelines
  • January 2018
  • 16 Pages
  • Global
From
Drug Overview: DPIV - Product Thumbnail Image

Drug Overview: DPIV

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • January 2018
  • 10 Pages
  • Global
From
Drug Overview: V180 - Product Thumbnail Image

Drug Overview: V180

  • Drug Pipelines
  • January 2018
  • 13 Pages
  • Global
From
Disease Overview: Dengue Vaccines - Product Thumbnail Image

Disease Overview: Dengue Vaccines

  • Drug Pipelines
  • January 2018
  • 83 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The V180 market is a segment of the global vaccine industry that focuses on the development and production of vaccines for the prevention of infectious diseases. Vaccines are a form of preventive medicine that can help protect individuals from a variety of illnesses, including influenza, measles, mumps, rubella, and hepatitis B. Vaccines are typically administered through injection, but can also be administered orally or nasally. The V180 market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, and vaccine manufacturers. These companies are responsible for the research, development, and production of vaccines, as well as the distribution and marketing of these products. Additionally, these companies are responsible for ensuring the safety and efficacy of the vaccines they produce. Some of the companies in the V180 market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more